Dr. Moo-Yeal Lee of 51���� is the co-author of an article published this month in the prestigious journal Nature Communications.

In “High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening,” Dr. Lee and his colleagues at Rensselaer Polytechnic Institute and the University of California, Berkeley, as well as Samsung Electro-Mechanics and Solidus Biosciences report on their development of the “Transfected Enzyme and Metabolism Chip” – TeamChip for short.

Their new microarray biochip can mimic drug metabolism in human livers and predict likely adverse drug reactions.

Read more on 51����’s ENGAGED blog: